본문 바로가기
KERD
논문KCI 등재

(-)-Epigalocatechin의 Fusobacterium nucleatum, Prevotella intermedia 및 Porphyromonas gingivalis에 대한 항균 효과

Antimicrobial effect of (-)-epigalocatechin on Fusobacterium nucleatum, Prevotella intermedia and Porphyromonas gingivalis

2

조회

0

다운로드

4

인용

0

참고문헌

키워드

주제분류치의학

초록

The aim of this study was to investigate the antimicrobial effect of (-)-epigalocatechin on Fusobacterium nucleatum, Prevotella intermedia, and Porphyromonas gingivalis. To test the antimicrobial effect of (-)-epigalocatechin,the minimum inhibitory concentration (MIC) of against 4 strains of F. nucleatum, 2 strains of P. intermedia, and 2 strains of P. gingivalis was measured by broth dilution method. Time-kill curves were assessed for susceptible bacteria, testing 0×MIC (control group), 0.5×MIC, 1×MIC, and 2×MIC for (-)-epigalocatechin, by counting viable bacteria after 3, 90,180, 360, 720, 1440 minutes. The MIC of (-)-epigalocatechin was 0.312-0.625, 0.625, and 0.625 mg/ml on the strains of F. nucleatum, P. intermedia, and P. gingivalis, respectively. Time-kill curves demonstrated (-)-epigalocatechin had bactericidal activity on P. intermedia ATCC 25611T, P. gingival is ATCC 53978, and F. nucleatum subsp. fusiforme ATCC 51190T. The results suggest that (-)-epigalocatechin can be useful in developing the oral hygiene product such as tooth past and gargling solution for the prevention of periodontal diseases.

Abstract

The aim of this study was to investigate the antimicrobial effect of (-)-epigalocatechin on Fusobacterium nucleatum, Prevotella intermedia, and Porphyromonas gingivalis. To test the antimicrobial effect of (-)-epigalocatechin,the minimum inhibitory concentration (MIC) of against 4 strains of F. nucleatum, 2 strains of P. intermedia, and 2 strains of P. gingivalis was measured by broth dilution method. Time-kill curves were assessed for susceptible bacteria, testing 0×MIC (control group), 0.5×MIC, 1×MIC, and 2×MIC for (-)-epigalocatechin, by counting viable bacteria after 3, 90,180, 360, 720, 1440 minutes. The MIC of (-)-epigalocatechin was 0.312-0.625, 0.625, and 0.625 mg/ml on the strains of F. nucleatum, P. intermedia, and P. gingivalis, respectively. Time-kill curves demonstrated (-)-epigalocatechin had bactericidal activity on P. intermedia ATCC 25611T, P. gingival is ATCC 53978, and F. nucleatum subsp. fusiforme ATCC 51190T. The results suggest that (-)-epigalocatechin can be useful in developing the oral hygiene product such as tooth past and gargling solution for the prevention of periodontal diseases.

참고문헌 (22)

  1. Gupta S, "Chronic infection in the aetiology of atherosclerosisfocus on Chlamydia pneumoniae", Atherosclerosis, 143(1), pp.1~6 (1999)
  2. Haraszthy VI, "Identification of periodontal pathogens in atheromatous plaques", J Periodontol, 71(10), pp.1554~1560 (2000)
  3. Darveau RP, "The microbial challenge in periodontitis", Periodontol 2000, 14, pp.12~32 (1997)
  4. Paster BJ, "Bacterial diversity in human subgingival plaque", J Bacteriol, 183(12), pp.3770~3783 (2001)
  5. Lacroix JM, "Detection and prevalence of the tetracycline resistance determinant Tet Q in the microbiota associated with adult periodontitis", Oral Microbiol Immunol, 11(4), pp.282~288 (1996)
  6. Olsvik B, "Tetracycline resistance in periodontal pathogens", Clin Infect Dis, 16(4), pp.S310~S313 (1993)
  7. Hattori Met, "Effect of tea polyphenols on glucan synthesis by glucosyltransferase from Streptococcus mutans", Chem Pharm Bull (Tokyo), 38(3), pp.717~720 (1990)
  8. 임성훈, "녹차 및 결명자 추출물의 교정용 브라켓과 치면 사이의 경계부에서 분리된 mutans streptococci에 대한 항균작용", 대한치과교정학회지, 33(5), pp.381~389 (2003), 대한치과교정학
  9. Hirasawa M, "Improvement of periodontal status by green tea catechin using a local delivery system: A clinical pilot study", J Periodontal Res, 37(6), pp.433~438 (2002)
  10. Murray PR, "Quantitative susceptibility test methods in major united states medical center", Antimicrob Agents Chemother, 20(1), pp.66~70 (1981)
  11. 이은숙, "녹차 및 결명자 추출물의 치주조직병 원인균에 대한 억제효과", 대한구강보건학회지, 27(4), pp.569~580 (2003), 대한구강보건학회
  12. Kolenbrander PE, "Coaggregation: specific adherence among human oral plaque bacteria", FASEB J, 7(5), pp.406~413 (1993)
  13. Diaz PI, "Fusobacterium nucleatum supports the growth of Porphyromonas gingivalis in oxygenated and carbon-dioxide-depleted environments", Microbiol, 148(Pt2), pp.467~472 (2002)
  14. Tew JG, "Fusobacterium nucleatummediated immunomodulation of the in vitro secondary antibody response to tetanus toxoid and Actinobacillus actinomycetemcomitans", J Periodontal Res, 22(6), pp.506~512 (1987)
  15. Dorn BR, "Invasion of human oral epithelial cells by Prevotella intermedia", Infect Immun, 66(12), pp.6054~6057 (1998)
  16. Kim SJ, "Prevotella intermedia lipopolysaccharide stimulates release of nitric oxide by inducing expression of inducible nitric oxide synthase", J Periodontal Res, 39(6), pp.424~431 (2004)
  17. Saito K, "Effects of glucose on formation of cytotoxic end-products and proteolytic activity of Prevotella intermedia, Prevotella nigrescens and Porphyromonas gingivalis", J Periodontal Res, 36(6), pp.355~360 (2001)
  18. Okamoto M, "Hemolytic and hemagglutinating activities of Prevotella intermedia and Prevotella nigrescens", FEMS Microbiol Lett, 178(2), pp.299~304 (1999)
  19. Papapanou PN, "“Checkerboard” assessments of periodontal microbiota and serum antibody responses: a case-control study", J Periodontol, 71(6), pp.885~897 (2000)
  20. Kook JK, "Detection of Tannerella forsythia and", or Prevotella intermedia might be useful for microbial predictive markers for the outcome of initial periodontal treatment in Koreans, 2005, pp.49(1), 9~16
  21. Socransky SS, "Microbial complexes in subgingival plaque", J Clin Periodontol, 25(2), pp.134~144 (1998)
  22. Li X, "Systemic diseases caused by oral infection", Clin Microbiol Rev, 13(4), pp.547~558 (2000)

관련 논문AI추천

이 간행물의 다른 논문 (8건)